Ledger.Open graph →
SEC Form D · filed July 22, 2020

Shoreline Biosciences, Inc

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LA JOLLA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Marios G. Fotiadis · La Jolla, CADirectorSteven G. Holtzman · La Jolla, CADirectorDan S. Kaufman · La Jolla, CADirectorKleanthis G. Xanthopoulos, Ph.D · La Jolla, CAExec · DirectorMarios G. Fotiadis · La Jolla, CADirectorSteven G. Holtzman · La Jolla, CADirectorDan S. Kaufman · La Jolla, CADirectorKleanthis G. Xanthopoulos, Ph.D · La Jolla, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗